FDA approves new drugs
· On Dec. 8, the U.S. Food and Drug Administration (FDA) approved: · Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
